[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100644066":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":11,"centralContacts":33,"locations":11,"responsibleParty":39,"collaborators":11,"id":43,"slug":44,"hasResults":45,"nctId":46,"briefTitle":47,"officialTitle":48,"acronym":11,"eligibilityCriteria":49,"healthyVolunteers":45,"sex":50,"minAge":51,"maxAge":52,"enrollmentInfo":53,"targetDuration":11,"studyType":56,"phases":57,"briefSummary":59,"conditions":60,"keywords":66,"overallStatus":70,"whyStopped":11,"lastUpdateSubmitDate":71,"lastUpdatePostDateStruct":72,"startDateStruct":75,"completionDateStruct":77,"leadSponsor":79,"locationsCount":11},{"fullName":5,"class":6},"Antalya City Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"quadro-iliac plane block (QIPB)","ACTIVE_COMPARATOR",null,[13],"Procedure: Quadro iliac Plane Block(QİPB)",{"label":15,"type":10,"description":11,"interventionNames":16},"pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve block",[17,18],"Procedure: PENG Block and LFCN Blok","Procedure: Lateral femoral cutaneous nerve block(LFCN)",[20,25,29],{"type":21,"name":22,"description":23,"armGroupLabels":24,"otherNames":11},"PROCEDURE","Quadro iliac Plane Block(QİPB)","Participants allocated to the QIPB group will receive an ultrasound-guided quadro-iliac plane block after spinal anesthesia. Following standard aseptic preparation, 30 mL of 0.25% bupivacaine will be administered into the target fascial plane under ultrasound guidance after confirming the absence of blood on aspiration.",[9],{"type":21,"name":26,"description":27,"armGroupLabels":28,"otherNames":11},"PENG Block and LFCN Blok","Participants in the PENG group will undergo an ultrasound-guided pericapsular nerve group (PENG) block after spinal anesthesia. A total of 20 mL of 0.25% bupivacaine will be administered.",[15],{"type":21,"name":30,"description":31,"armGroupLabels":32,"otherNames":11},"Lateral femoral cutaneous nerve block(LFCN)","Participants in the LFCN group will undergo an ultrasound-guided lateral femoral cutaneous nerve block after spinal anesthesia. A total of 10 mL of 0.25% bupivacaine will be administered.",[15],[34],{"name":35,"role":36,"phone":37,"phoneExt":11,"email":38},"MUSTAFA KILIN, Consultant Anesthesiologists","CONTACT","+905464569218","mustafa.kilin90@gmail.com",{"type":40,"investigatorFullName":41,"investigatorTitle":42,"investigatorAffiliation":5,"oldNameTitle":11,"oldOrganization":11},"PRINCIPAL_INVESTIGATOR","Mustafa Kılın","consultant anesthesiologist","100644066","penglfcn-block-vs-qipb-for-total-hip-arthroplasty-100644066",false,"NCT07667231","PENG+LFCN Block vs QIPB for Total Hip Arthroplasty","Comparison Between Quadro-iliac Plane Block (QIPB) and Pericapsular Nerve Group (PENG) Block Combined With Lateral Femoral Cutaneous Nerve Block for Total Hip Arthroplasty: a Randomized Controlled Trial","Inclusion Criteria:\n\n* Age between 18 and 80 years\n* American Society of Anesthesiologists physical status I-III\n* Scheduled for elective unilateral primary total hip arthroplasty\n* Surgery planned under spinal anesthesia\n* Ability to understand and use the Numeric Rating Scale\n* Written informed consent provided\n\nExclusion Criteria:\n\n* Refusal to participate\n* Revision total hip arthroplasty\n* Bilateral total hip arthroplasty\n* Contraindication to spinal anesthesia\n* Contraindication to peripheral nerve block\n* Known allergy to local anesthetics or study drugs\n* Coagulopathy or anticoagulant use incompatible with neuraxial\u002Fregional anesthesia\n* Infection at the block injection site\n* Pre-existing neurological deficit involving the operative lower extremity\n* Peripheral neuropathy\n* Chronic opioid use\n* Cognitive impairment or inability to communicate reliably\n* Severe hepatic or renal failure\n* Body mass index \\>35 kg\u002Fm²\n* Pregnancy","ALL","18 Years","80 Years",{"count":54,"type":55},60,"ESTIMATED","INTERVENTIONAL",[58],"NA","This randomized clinical trial aims to evaluate and compare the analgesic efficacy and functional outcomes of the quadro-iliac plane block (QIPB) and the pericapsular nerve group (PENG) block combined with lateral femoral cutaneous nerve(LFCN) block in patients undergoing total hip arthroplasty. The primary outcome is the Numeric Rating Scale (NRS) within the first 48 hours after surgery. Secondary outcomes include postoperative total opioid consumption, ıncidence of quadriceps motor block, time to first ambulation, block performance time, falls, length of hospital stay, block- related complications(hematoma,local anesthetic systemic complications, vascular puncture, and infection), patient satisfaction assessed using a Likert scale, and incidence of postoperative nausea and vomiting.",[61,62,63,64,65],"Quadro-Iliac Plane Block","Pericapsular Nerve Group Block (PENG Block)","Hip Arthroplasty, Total","Pain Management","Lateral Femoral Cutaneous Nerve Block",[67,68,69],"QIPB","PENG","LFCN","NOT_YET_RECRUITING","2026-06-20",{"date":73,"type":74},"2026-06-25","ACTUAL",{"date":76,"type":55},"2026-11-15",{"date":78,"type":55},"2027-09-15",{"name":5,"class":6}]